Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Repurposing ProTAME for Bladder Cancer: A Combined Therapeutic Approach Targeting Cell Migration and MMP Regulation

Nalkiran İ., Sevim Nalkıran H.
BIOLOGY-BASEL , cilt.14, sa.3, ss.1-21, 2025 (SCI-Expanded) identifier identifier

Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia

Kivrak M., Nalkiran İ., Sevim Nalkiran H.
CURRENT ISSUES IN MOLECULAR BIOLOGY , cilt.47, sa.3, ss.1-23, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Phytochemical Profile and Anticancer Potential of <i>Helichrysum arenarium</i> Extracts on Glioblastoma, Bladder Cancer, and Breast Cancer Cells

Nalkiran İ., Sevim Nalkiran H.
PHARMACEUTICALS , cilt.18, sa.2, ss.1-18, 2025 (SCI-Expanded) identifier identifier identifier

Identification and Characterization of a Novel Rat MAVS Variant Modulating NFκB Signaling

NALKIRAN İ., SEVİM NALKIRAN H.
BIOMOLECULES , cilt.15, sa.1, 2025 (SCI-Expanded) identifier identifier identifier

CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer

Sevim Nalkiran H., Biri I., Nalkıran İ., Uzun H., Durur S., Bedir R.
DIAGNOSTICS , cilt.15, sa.1, ss.1-21, 2025 (SCI-Expanded) identifier identifier identifier

An Electrochemical Immuno-cytosensor Modified with Nanofibers for the Determination of a Carcinoembryonic Antigen

Yildizbakan Z., Altuntaş D., SEVİM NALKIRAN H., Aslan S., Mamuk A. E., Koçak Ç., et al.
BIOCHIP JOURNAL , cilt.18, sa.3, ss.464-476, 2024 (SCI-Expanded) identifier identifier

Inhibition of O6-methylguanine-DNA-methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT-proficient cells

Akcora-Yildiz D., ÖZKAN T., Cetintav B., Yukselten Y., Calis S., Sevim-Nalkiran H., et al.
CHEMICAL BIOLOGY & DRUG DESIGN , cilt.103, sa.2, 2024 (SCI-Expanded) identifier identifier

The association of Sort1 expression with LDL subfraction and inflammation in patients with coronary artery disease

Atak M., Sevim Nalkiran H., Bostan M., Uydu H. A.
Acta Cardiologica , cilt.79, sa.2, ss.159-166, 2024 (SCI-Expanded) identifier identifier identifier

Targeting the anaphase-promoting complex/cyclosome (APC/C) enhanced antiproliferative and apoptotic response in bladder cancer

Sevim Nalkiran H., Akcora Yildiz D., Saydam F., Guzel A. I., Nalkiran İ.
Saudi Journal of Biological Sciences , cilt.30, sa.3, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Genetic variations in OLR1 gene associated with PCOS and atherosclerotic risk factors.

Sahin S. B., Nalkiran İ., Ayaz T., Irfan Guzel A., Eldes T., Calapoglu T., et al.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research , cilt.71, sa.2, ss.113-123, 2023 (SCI-Expanded) identifier identifier identifier

Prognostic importance of PD-L1 expression in bladder cancer patients.

Durur S., Uzun H., Bedir R., Nalkiran İ., Nalkiran H. S.
Journal of cancer research and therapeutics , cilt.19, sa.Suppl 2, 2023 (SCI-Expanded) Creative Commons License identifier

Development of MoS2 and Au nanoparticle including disposable CEA-based immuno-cytosensor platforms

BAL ALTUNTAŞ D., SEVİM NALKIRAN H., ASLAN S., YOLCU Z.
CHEMICAL PAPERS , cilt.76, sa.8, ss.5217-5229, 2022 (SCI-Expanded) identifier identifier

Anticancer effects of a novel herbal combination as a potential therapeutic candidate against lung cancer

SAYDAM F., Nalkiran H.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE , cilt.48, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Pelvic Radiation-Induced Testicular Damage: An Experimental Study at 1 Gray.

RAKICI S., Guzel A. İ., TUMKAYA L., Nalkiran H. S., MERCANTEPE T.
Systems biology in reproductive medicine , cilt.66, sa.2, ss.89-98, 2020 (SCI-Expanded) identifier identifier identifier

Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis

Nalkiran H., Sahin S. B., Ayaz T., Nalkiran I., Guzel A. I., Eldes T., et al.
BIOMARKERS IN MEDICINE , cilt.13, sa.4, ss.279-289, 2019 (SCI-Expanded) identifier identifier identifier

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)

Ha W., Sevim-Nalkiran H., ZAMAN A. M., MATSUDA K., Khasraw M., NOWAK A. K., et al.
SCIENTIFIC REPORTS , cilt.9, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Is neuroglial antigen 2 a potential contributor to cilengitide response in glioblastoma?

Nalkiran H., MCDONALD K. L.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.13, sa.2, ss.329-336, 2017 (SCI-Expanded) identifier identifier identifier

Effects of nimesulide on the small intestine mucositis induced by methotrexate in rats

ARSLAN A., ÖZÇİÇEK A., SÜLEYMAN B., ÇOBAN T. A., CIMEN F. K., Nalkiran H., et al.
EXPERIMENTAL ANIMALS , cilt.65, sa.4, ss.329-336, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Investigation of mucus obtained from different fish species on the acute pain induced with scalpel incision in paw of rats

Cetin N., SULEYMAN B., KUYRUKLUYILDIZ U., Nalkiran H., KIRAN A., GENCOGLU S., et al.
EXPERIMENTAL ANIMALS , cilt.65, sa.1, ss.77-85, 2016 (SCI-Expanded) identifier identifier identifier

Effects of Nimesulide on Oxidative Mucosal Injury Induced by Cisplatin in Rat Duodenum and Jejunum

ÖZÇİÇEK F., ÇANKAYA M., CIMEN F. K., Kafa A. H. T., Nalkiran H., SÜLEYMAN B., et al.
LATIN AMERICAN JOURNAL OF PHARMACY , cilt.35, ss.1110-1115, 2016 (SCI-Expanded) identifier identifier

Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?

Sevim H., Parkinson J. F., McDonald K. L.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.137, sa.11, ss.1705-1712, 2011 (SCI-Expanded) identifier identifier identifier

In vivo effects of Urtica urens (dwarf nettle) on the expression of CYP1A in control and 3-methylcholanthrene-exposed rats

Ozkarsli M., Sevim H., ŞEN A.
XENOBIOTICA , cilt.38, sa.1, ss.48-61, 2008 (SCI-Expanded) identifier identifier identifier
Diğer Dergilerde Yayınlanan Makaleler

Effects of Melaleuca alternifolia (Tea Tree) Oil and Vitamin E Combination on the Viability of Non-Small Cell Lung Cancer Cells

Nalkıran İ., Sevim Nalkıran H.
Rize Medical Journal , cilt.1, sa.2, ss.34-48, 2024 (Hakemli Dergi)

To Determine LDL Phenotypes Using Lipids, Lipoproteins, Apoproteins, and sdLDL Through Association Rule Mining

Atak M., Kıvrak M., Sevim Nalkıran H., Uydu H. A., Şatıroğlu Ö.
Journal of clinical practice and research , cilt.45, sa.6, ss.632-639, 2023 (ESCI)

Investigation of a Glioblastoma Risk-Associated SNP of the PTPRB Gene in Familial Glioblastoma

Sevim Nalkıran H., Rakıcı S., Nalkıran İ.
Journal of oncological sciences , cilt.9, sa.1, ss.15-22, 2023 (Scopus) Creative Commons License identifier identifier

Comparison of DNA isolation methods from mammalian sperm cells and development of a new protocol

SEVİM NALKIRAN H., NALKIRAN İ., RAKICI S., TÜMKAYA L., GÜZEL A. İ.
Medicine Science , cilt.10, sa.2, ss.440-443, 2021 (Hakemli Dergi) Creative Commons License

Effects of Hippophae rhamnoides extract on oxidative mucosal injuryinduced by cisplatin in rat jejunum.

Arslan A., ÖZÇİÇEK F., KESKİN ÇİMEN F., SEVİM H., GÜLABOĞLU M., ÇETİN N., et al.
Biomedical Research-India , cilt.29, sa.2, ss.401-407, 2018 (Hakemli Dergi)

?Prevention of Carbon Tetrachloride-Induced Hepatotoxicity by Urtica urens in Rats.

Sen A., Şahin B., Agus H. H., Bayav M., SEVİM NALKIRAN H., Semiz A.
JOURNAL OF APPLIED BIOLOGICAL SCIENCES , cilt.1, sa.3, ss.29-32, 2007 (Hakemli Dergi)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

Electrochemical Biosensor for Determination of Carcinoembryonic Antigen BiomarkerUsing Human Breast Ductal Adenocarcinoma, Human Ovarian Adenocarcinoma Cancer Cells

Yıldızbakan Z., Bal Altuntaş D., Sevim Nalkıran H., Aslan S., Yolcu Z.
16th Nanoscience and Nanotechnology Conference, TÜRKİYE, 2022, Ankara, Türkiye, 05 Ekim 2022, (Özet Bildiri) Sürdürülebilir Kalkınma

An Electrochemical Immunosensor Modified with Nanofibers for the Determination of a Carcinoembryonic Antigen

YILDIZBAKAN Z., BAL ALTUNTAŞ D., SEVİM NALKIRAN H., MAMUK A. E., KOÇAK Ç., ÜNLÜ C. G., et al.
16th Nanoscience and Nanotechnology Conference, Ankara, Türkiye, 05 Eylül 2022, (Özet Bildiri)

Anticancer properties of a new herbal combination as a potential lung cancer treatment candidate

SAYDAM F., SEVİM NALKIRAN H.
4th International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Türkiye, 18 Aralık 2021, (Özet Bildiri) Creative Commons License

Investigation of PD-L1 Gene Expression in Bladder Cancer Tissues

Durur S., Uzun H., Bedir R., Nalkıran İ., Sevim Nalkıran H.
8th Multidisciplinary Cancer Research Congress, 16 - 17 Ocak 2021, ss.102, (Özet Bildiri) Sürdürülebilir Kalkınma

Cytotoxic Effects of Melaleuca alternifolia (Tea Tree) Oil on A549 Non-Small Cell Lung Cancer and ARPE-19 Normal Epithelial Cells

SEVİM NALKIRAN H.
5th International Hippocrates Congress on Medical and Health Sciences, Online, Türkiye, 19 Aralık 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis

Sevim Nalkıran H.
Eurasian Congress on Molecular Biotechnology, Trabzon, Türkiye, 19 - 21 Eylül 2019, ss.17, (Özet Bildiri) Sürdürülebilir Kalkınma

Polikistik Over Sendromu Tanısı Almış Hastalarda Paraoksonaz 1 Genindeki Leu55Met ve Gln192Arg Polimorfizmlerinin Ateroskleroz riskiyle ilişkisinin Araştırılması

SEVİM NALKIRAN H., AYAZ T., NALKIRAN İ., GÜZEL A. İ., ELDEŞ T., YILDIZ Y.
2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu, Türkiye, 23 - 25 Şubat 2017, (Özet Bildiri)

Y CHROMOSOME MICRODELTIONS IN 102 CASES: IS THE INCIDENCE OF ACQUIRED NON-OBSTRUCTIVE AZOOSPERMIA INCREASING?

UZUN H., SEVİM NALKIRAN H., AKÇA N., EREN H., NALKIRAN İ., SAYDAM F., et al.
ESAU Meeting Bodrum Turkey, Muğla, Türkiye, 21 Mayıs 2017, ss.84, (Özet Bildiri)

Y Chromosome Microdeletions in 102 cases: Is the Incidence of Acquired Non-obstructıve Azoospermia Increasing?

UZUN H., SEVİM NALKIRAN H., AKÇA N., EREN H., NALKIRAN İ., SAYDAM F., et al.
ESAU Meeting, Muğla, Türkiye, 21 Mayıs 2017, (Özet Bildiri)

Effect of treating glioblastoma with a cytokine inhibitor, ibudilast, in combination with temozolomide on survival in a patient-derived xenograft model.

McDonald K. L., Ha W., Sevim H., Matsuda K., Khasraw M.
53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 06 Haziran 2017, cilt.35, (Özet Bildiri) identifier

EFFECT OF SORTILIN GEN EXPRESSION ON LDL SUBFRACTIONS AND SEVERITY OF CORONARY ARTERY DISEASE

UYDU H. A., ATAK M., BOSTAN M., SEVİM NALKIRAN H., MALKOÇ M., PINARBAŞ E., et al.
85th Congress of the European Atherosclerosis Society, Brisbane, Avustralya, 23 - 26 Nisan 2017, cilt.11, sa.263, ss.0-104, (Özet Bildiri)

Simultane Familyal Glioblastom: İki Kardeş Glioblastom Vakası

RAKICI S., SEVİM NALKIRAN H., ÇETİN B., BEDİR R.
22. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.153, (Tam Metin Bildiri)

Investigation of Association Between Paraoxonase-1 L55M (RS854560) and Q192R (RS662) Polymorphisms and Potential Atherosclerotic Risk Factors in PCOS Patients Patients (Polikistik Over Sendromu Tanısı Almış Hastalarda Paraoksonaz 1 Genindeki Leu55Met ve Gln192Arg Polimorfizmlerinin Ateroskleroz riskiyle ilişkisinin Araştırılması)

SEVİM NALKIRAN H., AYAZ T., NALKIRAN İ., GÜZEL A. İ., DURAKOĞLUGİL T., YILDIZ Y.
2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu, İzmir, Türkiye, 23 - 25 Şubat 2017, cilt.9, ss.27, (Özet Bildiri) Creative Commons License

Repurposing Ibudilast in combination with temozolomide for glioblastoma

McDonald K., Ha W., SEVİM NALKIRAN H., Khasraw M.
21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, Scottsdale, Arizona, Arizona, Amerika Birleşik Devletleri, 17 - 20 Kasım 2016, cilt.18, (Özet Bildiri) Creative Commons License

Repurposing Ibudilast in combination with temozolomide for glioblastoma

McDonald K., Ha W., SEVİM NALKIRAN H., Chung L., Baxter R., Khasraw M.
13th Asian Society for Neuro-Oncology (ASNO) Meeting/9th COGNO Annual Scientific Meeting, Sydney, Avustralya, 11 - 14 Eylül 2016, ss.67, (Özet Bildiri) Creative Commons License

MIF/CD74 guided therapeutic strategy for relapsed glioblastoma patients

Mcdonald K. L., SEVİM NALKIRAN H., Ha W., Chung L., Baxter R.
105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), California, Amerika Birleşik Devletleri, 5 - 09 Nisan 2014, cilt.74, (Özet Bildiri) identifier

MIF-CD74 GUIDED THERAPEUTIC STRATEGY FOR THE UPFRONT TREATMENT OF GBM PATIENTS WITH AN UNMETHYLATED MGMT PROMOTER

McDonald K. L., Ha W., Sevim H.
20th International Conference on Brain Tumor Research and Therapy, California, Amerika Birleşik Devletleri, 20 - 22 Temmuz 2014, cilt.16, (Özet Bildiri) Creative Commons License identifier

Improved Responsiveness to Temozolomide by Blocking MIF Expression in Glioblastoma

McDonald K. L., SEVİM NALKIRAN H.
Worldwide Innovative Networking in Personalized Cancer Medicine WIN 2013 Symposium-Personal Cancer Medicine: From Innovation to implementation, Paris, Fransa, 10 - 12 Temmuz 2013, ss.7, (Tam Metin Bildiri) Creative Commons License

Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival?

SEVİM NALKIRAN H., Chung L., Wheeler H. R., Baxter R. C., McDonald K. L.
European Association of Neuro-oncology (EANO) 10th meeting, Marsilya, Fransa, 6 - 07 Eylül 2012, sa.14, (Özet Bildiri) Creative Commons License

Aberrant expression of Low-molecular-weight proteins associated with response to conventional concurrent chemoradiotherapy treatment

SEVİM NALKIRAN H., Chung L., Wheeler H. R., Baxter R. C., McDonald K. L.
16th Annual Scientific Meeting & Education Day of the Society for Neuro-Oncology, Garden Grove, Amerika Birleşik Devletleri, 17 - 20 Kasım 2011, cilt.13, (Tam Metin Bildiri) Creative Commons License

Protein biomarker discovery in glioblastoma using SELDI-TOF-MS

SEVİM NALKIRAN H., Chung L., Wheeler H. R., Baxter R. C., McDonald K. L.
102nd Annual Meeting of the American Association for Cancer Research, Orlando, Amerika Birleşik Devletleri, 2 - 06 Nisan 2011, cilt.71, sa.5094, ss.71, (Tam Metin Bildiri)

Determining Biological Factors Associated with chemotherapy response in Glioblastoma Patients?

SEVİM NALKIRAN H., Maleki S., Messina M., Robinson B. G., McDonald K. L.
XXVIth Annual Scientific Research Meeting, Sydney, Avustralya, 25 Kasım 2009, ss.51, (Tam Metin Bildiri)

In vivo effects of Urtica urens seed extracts on the cytochrome P450-dependent monooxygenases in the liver, lung and kidney of control and 3-methylcholanthrene-exposed rats

SEN A., Agus H. H., Bayav M., SEVİM NALKIRAN H.
14th North American ISSX Meeting, Puerto Rico, Amerika Birleşik Devletleri, 22 - 26 Ekim 2006, cilt.38, ss.55-56, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

Karaciğer Koruyucu Urtica urens: Sıçanlarda Karbontetraklorür?ün Neden Olduğu Karaciğer Toksisitesinin U. urens ile Giderilmesi

Sen A., Şahin B., Bayav M., Agus H. H., SEVİM NALKIRAN H., Semiz A.
18. Ulusal Biyoloji Kongresi, Aydın, Türkiye, 26 - 30 Haziran 2006, sa.154, ss.59, (Tam Metin Bildiri)

In vivo assessment of Urtica urens supplementation on rat xenobiotic metabolizing enzymes

Sen A., Agus H. H., Bayav M., SEVİM NALKIRAN H.
Federation of European Biochemical Societies, İstanbul, Türkiye, 25 - 29 Haziran 2006, cilt.273, ss.300, (Tam Metin Bildiri)
Metrikler

Yayın

57

Atıf (WoS)

99

H-İndeks (WoS)

6

H-İndeks (Scopus)

5

Atıf (Diğer Toplam)

87

Proje

12

Tez Danışmanlığı

2

Açık Erişim

12
BM Sürdürülebilir Kalkınma Amaçları